glp 1 agonist vs sglt2 inhibitor inhibitors or GLP-1 receptor agonists as second-line therapy in | VHRM GLP-1 Receptor Agonists and SGLT2
Description
But for most, he says, there's an element of negative reinforcement
Rondanelli M, Perna S, Riva A, Petrangolini G, Di Paolo E, Gasparri C
45,46 As shown in Figure 2 , GLP-1RAs penetrate the blood-brain barrier and directly activate GLP-1 receptors in the hypothalamus, especially within the ARH nucleus, a key center for appetite regulation
This study supports the ongoing monitoring of tirzepatide to ensure its safe use in clinical settings [17]
Endocr J
